Anti-Inflammatory Drug Design Using a Molecular Hybridization Approach

• Main Authors: Jean Leandro dos Santos, Man Chin Chung, Ednir Oliveira Vizioli, Priscila Longhin Bosquesi, Thais Regina Ferreira Melo
• Format: Article
• Language: English
• Published: MDPI AG 2011-10-01
• Series: Pharmaceuticals
• Subjects: anti-inflammatory; hybridization; multiple-ligands; mutual prodrug
• Online Access: http://www.mdpi.com/1424-8247/4/11/1450/

The design of new drugs with better physiochemical properties, adequate absorption, distribution, metabolism, and excretion, effective pharmacologic potency and lacking toxicity remains is a challenge. Inflammation is the initial trigger of several different diseases, such as Alzheimer’s disease, asthma, atherosclerosis, colitis, rheumatoid arthritis, depression, cancer; and disorders such as obesity and sexual dysfunction. Although inflammation is not the direct cause of these disorders, inflammatory processes often increase related pain and suffering. New anti-inflammatory drugs developed using molecular hybridization techniques to obtain multiple-ligand drugs can act at one or multiple targets, allowing for synergic action and minimizing toxicity. This work is a review of new anti-inflammatory drugs developed using the molecular modification approach.